Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression
2023 · Cell Death and Disease · 129 citations
https://doi.org/10.1038/s41419-023-05568-8
G
Giulia Bon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
1.0K
Citations
16
h-index
20
i10-index
Giulia Bon is an academic researcher from Cellular Therapeutics (United Kingdom). The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 16, co-authored 60 publications.
ORCID: 0000-0002-5409-5864Papers by this author
worksLoss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
2020 · Journal of Experimental & Clinical Cancer Research · 72 citations
https://doi.org/10.1186/s13046-020-01797-3
Preparative isotachophoresis of human plasma high density lipoproteins HDL2 and HDL3.
1981 · Journal of Lipid Research · 13 citations
https://doi.org/10.1016/s0022-2275(20)37337-5
<i>HER2</i> mutation as an emerging target in advanced breast cancer
2024 · Cancer Science · 11 citations
https://doi.org/10.1111/cas.16148
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat